We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Consumer Discretionary 13.7%
3 Healthcare 13.3%
4 Industrials 7.34%
5 Financials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIHD
3576
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$20K ﹤0.01%
+11,800
New +$22.5K
TLGT
3577
DELISTED
Teligent, Inc
TLGT
$18K ﹤0.01%
2,804
-22,312
-89% -$182K
FBIO icon
3578
Fortress Biotech
FBIO
$96.7M
$17K ﹤0.01%
+756
New +$19.4K
SSI
3579
DELISTED
Stage Stores Inc
SSI
$15K ﹤0.01%
19,106
IBRX icon
3580
ImmunityBio
IBRX
$7.94B
$13K ﹤0.01%
13,200
-1,508
-10% -$1.74K
HSTO
3581
DELISTED
Histogen Inc. Common Stock
HSTO
$13K ﹤0.01%
257
-181
-41% -$31.4K
GEN
3582
DELISTED
Genesis Healthcare, Inc.
GEN
$13K ﹤0.01%
10,700
-1,178
-10% -$1.5K
ASCMA
3583
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$12K ﹤0.01%
11,203
CTIC
3584
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$10K ﹤0.01%
11,302
AMR
3585
DELISTED
Alta Mesa Resources Inc
AMR
$6K ﹤0.01%
43,000
PES
3586
DELISTED
Pioneer Energy Services Corp.
PES
$6K ﹤0.01%
25,016
-89,738
-78% -$98.1K
AREX
3587
DELISTED
Approach Resources Inc.
AREX
$3K ﹤0.01%
11,329
UPL
3588
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$2K ﹤0.01%
12,030
-42,710
-78% -$18.3K
AAT
3589
American Assets Trust
AAT
$1.4B
-5,875
Closed -$269K
ABG icon
3590
PUT
Asbury Automotive
ABG
$3.85B
-9,800
Closed -$680K
ACB
3591
Aurora Cannabis
ACB
$249M
-604
Closed -$656K
ACTG icon
3592
Acacia Research
ACTG
$443M
-251,980
Closed -$821K
ADBE icon
3593
PUT
Adobe
ADBE
$110B
-6,600
Closed -$1.76M
ADNT icon
3594
Adient
ADNT
$1.52B
-35,161
Closed -$723K
AEM icon
3595
CALL
Agnico Eagle Mines
AEM
$110B
-6,500
Closed -$283K
AGCO icon
3596
PUT
AGCO
AGCO
$7.65B
-30,300
Closed -$2.11M
AGIO icon
3597
PUT
Agios Pharmaceuticals
AGIO
$1.96B
-15,000
Closed -$1.01M
AGNC icon
3598
AGNC Investment
AGNC
$13B
-57,000
Closed -$1.03M
AIT icon
3599
CALL
Applied Industrial Technologies
AIT
$12.5B
-4,800
Closed -$285K
ALGN icon
3600
Align Technology
ALGN
$11.5B
-1,000
Closed -$302K

Similar funds

David Shaw's Q2 2019 Portfolio in Review

As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
  • David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • David Shaw opened 499 new positions and closed 416 in Q2 2019.
  • David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.